Qualitative and quantitative changes in coronary plaque associated with atorvastatin therapy

Circulation Journal

Volumn 73, Issue 4, 2009, Pages 718-725

  Hirayama, Atsushi ^a   Saito, Satoshi ^a   Ueda, Yasunori ^b   Takayama, Tadateru ^a   Honye, Junko ^a   Komatsu, Sei ^g   Yamaguchi, Osamu ^d   Li, Yuxin ^a   Yajima, Junji ^e   Nanto, Shinsuke ^c   Takazawa, Kenji ^f   Kodama, Kazuhisa ^b  

^a NIHON UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b OSAKA POLICE HOSPITAL   (Japan)

^c KANSAI ROSAI HOSPITAL   (Japan)

^d OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^e THE CARDIOVASCULAR INSTITUTE   (Japan)

^f TOKYO MEDICAL UNIVERSITY HACHIOJI MEDICAL CENTER   (Japan)

^g Amagasaki Central Hospital   (Japan)

Author keywords

Angioscopy; Coronary disease; IVUS; Plaque; Statins

Indexed keywords

ATORVASTATIN; C REACTIVE PROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGED; ANGIOSCOPY; ARTICLE; ATHEROMA; ATHEROSCLEROTIC PLAQUE; CLINICAL FEATURE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG EFFICACY; FEMALE; HUMAN; INTRAVASCULAR ULTRASOUND; LIPID BLOOD LEVEL; MALE; PROTEIN BLOOD LEVEL; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS;

AGED; ANGIOSCOPY; ANTICHOLESTEREMIC AGENTS; CORONARY ARTERY DISEASE; CORONARY VESSELS; FEMALE; HEPTANOIC ACIDS; HUMANS; MALE; MIDDLE AGED; PYRROLES; TIME FACTORS; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 65649092544     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-08-0755     Document Type: Article

References (27)

1. Cannon CP, Braunwald E, McCabe CH, Rader DJ, Rouleau JL, Belder R, et al. Intensive versus moderate lipid lowering with statins after acute coronary syndromes. N Engl J Med 2004; 350: 1495-1504. (Pubitemid 38477774)
2. LaRosa JC, Grundy SM, Waters DD, Shear C, Barter P, Fruchart JC, et al. Intensive lipid lowering with atorvastatin in patients with stable coronary disease. N Engl J Med 2005; 352: 1425-1435. (Pubitemid 40471450)
3. Pedersen TR, Faergeman O, Kastelein JJ, Olsson AG, Tikkanen MJ, Holme I, et al. High-dose atorvastatin versus usual-dose simvastatin for secondary prevention after myocardial infarction: The IDEAL study [a randomized controlled trial]. JAMA 2005; 294: 2437-2445. (Pubitemid 41627921)
4. Ueda Y, Ohtani T, Shimizu M, Hirayama A, Kodama K. Assessment of plaque vulnerability by angioscopic classification of plaque color. Am Heart J 2004; 148: 333-335. (Pubitemid 39092801)
5. Waxman S, Mittleman MA, Zarich SW, Fitzpatrick PJ, Lewis SM, Leeman DE, et al. Angioscopic assessment of coronary lesions underlying thrombus. Am J Cardiol 1997; 79: 1106-1109. (Pubitemid 27217069)
6. Thieme T, Wernecke KD, Meyer R, Brnadenstein E, Habedank D, Hinz A, et al. Angioscopic evaluation of atherosclerotic plaques: Validation by histomorphologic analysis and association with stable and unstable coronary syndromes. J Am Coll Cardiol 1996; 28: 1-6. (Pubitemid 26266615)
7. Ueda Y, Asakura M, Yamaguchi O, Hirayama A, Hori M, Kodama K. The healing process of infarct-related plaques: Insights from 18 months of serial angioscopic follow-up. J Am Coll Cardiol 2001; 38: 1916-1922. (Pubitemid 33116564)
8. Asakura M, Ueda Y, Yamaguchi O, Adachi T, Hirayama A, Hori M, et al. Extensive development of vulnerable plaques as a pan-coronary process in patients with myocardial infarction: An angioscopic study. J Am Coll Cardiol 2001; 37: 1284-1288.
9. Nissen S. Coronary angiography and intravascular ultrasound. Am J Cardiol 2001; 87: 15A-20A. (Pubitemid 32178480)
10. Takano M, Mizuno K, Yokoyama S, Seimiya K, Ishibashi F, Okamatsu K, et al. Changes in coronary plaque color and morphology by lipid-lowering therapy with atorvastatin: Serial evaluation by coronary angioscopy. J Am Coll Cardiol 2003; 42: 680-686. (Pubitemid 37000185)
11. Nissen SE, Tuzcu EM, Schoenhagen P, Brown BG, Ganz P, Vogel RA, et al. Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: A randomized controlled trial. JAMA 2004; 291: 1071-1080. (Pubitemid 38541684)
12. Okazaki S, Yokoyama T, Miyauchi K, Shimada K, Kurata T, Sato H, et al. Early statin treatment in patients with acute coronary syndrome: Demonstration of the beneficial effect on atherosclerotic lesions by serial volumetric intravascular ultrasound analysis during half a year after coronary event: The ESTABLISH Study. Circulation 2004; 110: 1061-1068. (Pubitemid 39319003)
13. Li Y, Honye J, Saito S, Takayama T, Yokoyama S, Saruya T, et al. Variability in quantitative measurement of the same segment with two different intravascular ultrasound systems: In vivo and in vitro studies. Catheter Cardiovasc Interv 2004; 62: 175-180. (Pubitemid 38788693)
14. Ohtani T, Ueda Y, Mizote I, Oyabu J, Okada K, Hirayama A, et al. Number of yellow plaques detected in a coronary artery is associated with future risk of acute coronary syndrome: Detection of vulnerable patients by angioscopy. J Am Coll Cardiol 2006; 47: 2194-2200. (Pubitemid 43795053)
15. Kawasaki M, Takatsu H, Noda T, Sano K, Ito Y, Hayakawa K, et al. In vivo quantitative tissue characterization of human coronary arterial plaques by use of integrated backscatter intravascular ultrasound and comparison with angioscopic findings. Circulation 2002; 105: 2487-2492. (Pubitemid 34568969)
16. Kubo T, Imanishi T, Takarada S, Kuroi A, Ueno S, Yamano T, et al. Implication of plaque color classification for assessing plaque vulnerability: A coronary angioscopy and optical coherence tomography investigation. J Am Coll Cardiol Interv 2008; 1: 74-80.
17. Ray KK, Cannon CP, McCabe CH, Cairns R, Tonkin AM, Sacks FM, et al. Early and late benefits of high-dose atorvastatin in patients with acute coronary syndromes: Results from the PROVE IT-TIMI 22 trial. J Am Coll Cardiol 2005; 46: 1405-1410. (Pubitemid 41446173)
18. Schwartz GG, Olsson AG, Ezekowitz MD, Ganz P, Oliver MF, Walters D, et al. Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: The MIRACL study: A randomized controlled trial. JAMA 2001; 285: 1711-1718. (Pubitemid 32259905)
19. Nissen SE, Nicholls SJ, Sipahi I, Libby P, Raichlen JS, Ballantyne CM, et al. Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: The ASTEROID trial. JAMA 2006; 295: 1556-1565.
20. Tani S, Watanabe I, Anazawa T, Kawamata H, Tachibana E, Furukawa K, et al. Effect of pravastatin on malondialdehyde-modified lowdensity lipoprotein levels and coronary plaque regression as determined by three-dimensional intravascular ultrasound. Am J Cardiol 2005; 96: 1089-1094. (Pubitemid 41416600)
21. Yokoyama M, Komiyama N, Courtney BK, Nakayama T, Namikawa S, Kuriyama N, et al. Plasma low-density lipoprotein reduction and structural effects on coronary atherosclerotic plaques by atorvastatin as clinically assessed with intravascular ultrasound radio-frequency signal analysis: A randomized prospective study. Am Heart J 2005; 150: 287. (Pubitemid 41121948)
22. Kawasaki M, Sano K, Okubo M, Yokoyama H, Ito Y, Murata I, et al. Volumetric quantitative analysis of tissue characteristics of coronary plaques after statin therapy using three-dimensional integrated backscatter intravascular ultrasound. J Am Coll Cardiol 2005; 45: 1946-1953.
23. Schartl M, Bocksch W, Koschyk DH, Voelker W, Karsch KR, Kreuzer J, et al. Use of intravascular ultrasound to compare effects of different strategies of lipid-lowering therapy on plaque volume and composition in patients with coronary artery disease. Circulation 2001; 104: 387-392. (Pubitemid 32678266)
24. Crisby M, Nordin-Fredriksson G, Shah PK, Yano J, Zhu J, Nilsson J. Pravastatin treatment increases collagen content and decreases lipid content, inflammation, metalloproteinases, and cell death in human carotid plaques: Implications for plaque stabilization. Circulation 2001; 103: 926-933. (Pubitemid 32183796)
25. Aikawa M, Rabkin E, Okada Y, Voglic SJ, Clinton SK, Brinckerhoff CE, et al. Lipid lowering by diet reduces matrix metalloproteinase activity and increases collagen content of rabbit atheroma: A potential mechanism of lesion stabilization. Circulation 1998; 97: 2433-2444. (Pubitemid 28278188)
26. Underhill HR, Yuan C, Zhao XQ, Kraiss LW, Parker DL, Saam T, et al. Effect of rosuvastatin therapy on carotid plaque morphology and composition in moderately hypercholesterolemic patients: A highresolution magnetic resonance imaging trial. Am Heart J 2008; 155: 584 e1-e8.
27. Athyros VG, Papageorgiou AA, Mercouris BR, Athyrou VV, Symeonidis AN, Basayannis EO, et al. Treatment with atorvastatin to the National Cholesterol Educational Program goal versus 'usual' care in secondary coronary heart disease prevention: The GREek Atorvastatin and Coronary-heart-disease Evaluation (GREACE) study. Curr Med Res Opin 2002; 18: 220-228.